The therapeutic potential of the endocannabinoid system for Alzheimer’s disease(PubMed)
Endocannabinoid signalling in Alzheimer’s disease (PubMed)
A molecular link between the active component of marijuana and Alzheimer’s disease pathology (PubMed)
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells (PubMed)
The Potential Therapeutic Effects of THC on Alzheimer’s Disease (PubMed)
Cannabinoids for the treatment of dementia (PubMed)
Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression (PubMed)
Cannabidiol: A promising drug for neurodegenerative disorders? (PubMed)
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition(PubMed)
The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses (PubMed)
The role of phytochemicals in the treatment and prevention of dementia (PubMed)
Cannabinoids for the treatment of dementia (PubMed)
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement (PubMed)
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic (Pub Med)
Can Marijuana Prevent Alzheimer’s? (Next Avenue)
